{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:56:14Z","timestamp":1790052974431,"version":"4.0.1"},"reference-count":379,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is still a heterogeneous neurodegenerative disorder that can be identified clinically and biologically, without a strong set of biomarkers that can adequately measure its fast rate of progression and molecular heterogeneity. In this review, we intend to consolidate the most relevant and timely advances in ALS biomarker discovery, in order to begin to bring molecular, imaging, genetic, and digital areas together for potential integration into a precision medicine approach to ALS. Our goal is to begin to display how several biomarkers in development (e.g., neurofilament light chain (NfL), phosphorylated neurofilament heavy chain (pNfH), TDP-43 aggregates, mitochondrial stress markers, inflammatory markers, etc.) are changing our understanding of ALS and ALS dynamics. We will attempt to provide a framework for thinking about biomarkers in a systematic way where our candidates are not signals alone but part of a tethered pathophysiological cascade. We are particularly interested in the fast progressor phenotype, a devastating and under-characterized subset of ALS due to a rapid axonal degeneration, early respiratory failure, and very short life span. We will try to highlight the salient molecular features of this ALS subtype, including SOD1 A5V toxicity, C9orf72 repeats, FUS variants, mitochondrial collapse, and impaired autophagy mechanisms, and relate these features to measurable blood and CSF (biomarkers) and imaging platforms. We will elaborate on several interesting tools, for example, single-cell transcriptomics, CSF exosomal cargo analysis, MRI techniques, and wearable sensor outputs that are developing into high-resolution windows of disease progression and onset. Instead of providing a static catalog, we plan on providing a conceptual roadmap to integrate biomarker panels that will allow for earlier diagnosis, real-time disease monitoring, and adaptive therapeutic trial design. We hope this synthesis will make a meaningful contribution to the shift from observational neurology to proactive biologically informed clinical care in ALS. Although there are still considerable obstacles to overcome, the intersection of a precise molecular or genetic association approach, digital phenotyping, and systems-level understandings may ultimately redefine how we monitor, care for, and treat this challenging neurodegenerative disease.<\/jats:p>","DOI":"10.3390\/ijms26168072","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T08:40:48Z","timestamp":1755765648000},"page":"8072","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Blueprint of Collapse: Precision Biomarkers, Molecular Cascades, and the Engineered Decline of Fast-Progressing ALS"],"prefix":"10.3390","volume":"26","author":[{"given":"Matei","family":"\u0218erban","sequence":"first","affiliation":[{"name":"Puls Med Association, 051885 Bucharest, Romania"},{"name":"Department of Neurosurgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corneliu","family":"Toader","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u0103zvan-Adrian","family":"Covache-Busuioc","sequence":"additional","affiliation":[{"name":"Puls Med Association, 051885 Bucharest, Romania"},{"name":"Department of Neurosurgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lucchi, C., Simonini, C., Rustichelli, C., Avallone, R., Zucchi, E., Martinelli, I., Biagini, G., and Mandrioli, J. (2024). Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients. Biomolecules, 14.","DOI":"10.3390\/biom14091076"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/21678421.2024.2405587","article-title":"Profiles of disease progression and predictors of mortality in Colombian patients with amyotrophic lateral sclerosis: A comprehensive longitudinal study","volume":"26","year":"2025","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"eadg3665","DOI":"10.1126\/scitranslmed.adg3665","article-title":"Cortical hyperexcitability in mouse models and patients with amyotrophic lateral sclerosis is linked to noradrenaline deficiency","volume":"16","author":"Benetton","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e0313307","DOI":"10.1371\/journal.pone.0313307","article-title":"Fasciculation potentials are related to the prognosis of amyotrophic lateral sclerosis","volume":"19","author":"Ohnari","year":"2024","journal-title":"PLoS ONE"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41540-024-00449-y","article-title":"Network medicine informed multiomics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral Sclerosis","volume":"10","author":"Yu","year":"2024","journal-title":"Npj Syst. Biol. Appl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e16540","DOI":"10.1111\/ene.16540","article-title":"Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment","volume":"32","author":"Trojsi","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/21678421.2024.2309989","article-title":"ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional decline","volume":"25","author":"Hamatani","year":"2024","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40035-023-00389-3","article-title":"Novel data-driven subtypes and stages of brain atrophy in the ALS\u2013FTD spectrum","volume":"12","author":"Shen","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00415-024-12774-7","article-title":"Exploring clinical chemistry markers in amyotrophic lateral sclerosis: Insights into survival and disease trajectories","volume":"272","author":"Psychogios","year":"2025","journal-title":"J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/1673-5374.344839","article-title":"Diffusion tensor imaging reveals brain structure changes in dogs after spinal cord injury","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"105104","DOI":"10.1016\/j.ebiom.2024.105104","article-title":"Remote monitoring of amyotrophic lateral sclerosis using wearable sensors detects differences in disease progression and survival: A prospective cohort study","volume":"103","author":"Meyjes","year":"2024","journal-title":"eBioMedicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/21678421.2023.2165946","article-title":"Frequency of C9orf72 and SOD1 mutations in 302 sporadic ALS patients from three German ALS centers","volume":"24","author":"Yilmaz","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41467-023-37630-6","article-title":"Integrated transcriptome landscape of ALS identifies genome instability linked to TDP-43 pathology","volume":"14","author":"Ziff","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Giannakou, M., Akrani, I., Tsoka, A., Myrianthopoulos, V., Mikros, E., Vorgias, C., and Hatzinikolaou, D.G. (2024). Discovery of Novel Inhibitors against ALS-Related SOD1(A4V) Aggregation through the Screening of a Chemical Library Using Differential Scanning Fluorimetry (DSF). Pharmaceuticals, 17.","DOI":"10.3390\/ph17101286"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"123290","DOI":"10.1016\/j.jns.2024.123290","article-title":"Efficacy of Radicava\u00ae IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trial","volume":"467","author":"Pioro","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102495","DOI":"10.1016\/j.eclinm.2024.102495","article-title":"Effects of tofersen treatment in patients with SOD1-ALS in a \u201creal-world\u201d setting\u2014A 12-month multicenter cohort study from the German early access program","volume":"69","author":"Wiesenfarth","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/21678421.2023.2285443","article-title":"Predicting amyotrophic lateral sclerosis (ALS) progression with machine learning","volume":"25","author":"Guo","year":"2024","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Weiss, A., Gilbert, J.W., Flores, I.V.R., Belgrad, J., Ferguson, C., Dogan, E.O., Wightman, N., Mocarski, K., Echeverria, D., and Summers, A. (2024). RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice. bioRxiv.","DOI":"10.1101\/2024.06.20.599943"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1038\/s41467-022-33332-7","article-title":"CRISPR\/Cas9-mediated excision of ALS\/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro","volume":"13","author":"Meijboom","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1054006","DOI":"10.3389\/fphar.2022.1054006","article-title":"New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Dabrowska, S., Turano, E., Scambi, I., Virla, F., Nodari, A., Pezzini, F., Gali\u00e8, M., Bonetti, B., and Mariotti, R. (2024). A Cellular Model of Amyotrophic Lateral Sclerosis to Study the Therapeutic Effects of Extracellular Vesicles from Adipose Mesenchymal Stem Cells on Microglial Activation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115707"},{"key":"ref_23","unstructured":"Amylyx Pharmaceuticals Inc (2025, February 08). AMX0035 for Amyotrophic Lateral Sclerosis\u2014Compassionate Use Protocol, clinicaltri-als.gov, Clinical Trial Registration NCT04516096, April 2023, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04516096."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eadf6895","DOI":"10.1126\/sciadv.adf6895","article-title":"Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis","volume":"9","author":"Oiwa","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1038\/s41598-022-12191-8","article-title":"Heat shock protein Grp78\/BiP\/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology","volume":"12","author":"Scott","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/21678421.2023.2215838","article-title":"PRECISION ALS\u2014An integrated pan European patient data platform for ALS","volume":"24","author":"McFarlane","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"fcae389","DOI":"10.1093\/braincomms\/fcae389","article-title":"T1-weighted MRI texture analysis in amyotrophic lateral sclerosis patients stratified by the D50 progression model","volume":"6","author":"Parnianpour","year":"2024","journal-title":"Brain Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"28110","DOI":"10.1038\/s41598-024-79511-y","article-title":"Identifying amyotrophic lateral sclerosis using diffusion tensor imaging, and correlation with neurofilament markers","volume":"14","author":"Qin","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16851","DOI":"10.1038\/s41598-024-67940-8","article-title":"A novel digital tool for detection and monitoring of amyotrophic lateral sclerosis motor impairment and progression via keystroke dynamics","volume":"14","author":"Acien","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"753242","DOI":"10.3389\/fnagi.2021.753242","article-title":"Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study","volume":"13","author":"Vacchiano","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"fcad211","DOI":"10.1093\/braincomms\/fcad211","article-title":"Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosis","volume":"5","author":"Thompson","year":"2023","journal-title":"Brain Commun."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zimyanin, V.L., Pielka, A.-M., Gla\u00df, H., Japtok, J., Gro\u00dfmann, D., Martin, M., Deussen, A., Szewczyk, B., Deppmann, C., and Zunder, E. (2023). Live Cell Imaging of ATP Levels Reveals Metabolic Compartmentalization within Motoneurons and Early Metabolic Changes in FUS ALS Motoneurons. Cells, 12.","DOI":"10.1101\/2023.03.22.533787"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1038\/s41598-024-67165-9","article-title":"Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression","volume":"14","author":"Femiano","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Correia, J.P., Gromicho, M., Pronto-Laborinho, A.C., Oliveira Santos, M., and de Carvalho, M. (2024). Creatine Kinase and Respiratory Decline in Amyotrophic Lateral Sclerosis. Brain Sci., 14.","DOI":"10.3390\/brainsci14070661"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Barbato, F., Bombaci, A., Colacicco, G., Bruno, G., Ippolito, D., Pota, V., Dongiovanni, S., Sica, G., Bocchini, G., and Valente, T. (2024). Chest Dynamic MRI as Early Biomarker of Respiratory Impairment in Amyotrophic Lateral Sclerosis Patients: A Pilot Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13113103"},{"key":"ref_36","first-page":"6","article-title":"Utility of expression of 4-hydroxynonenal tested by immunohistochemistry for cervical cancer","volume":"23","author":"Tsoneva","year":"2024","journal-title":"Prz. Menopauzalny"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"106078","DOI":"10.1016\/j.psyneuen.2023.106078","article-title":"A comparative meta-analysis of peripheral 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG) or 8-oxo-7,8-dihydro-2\u2032-deoxyguanosine (8-oxo-dG) levels across mood episodes in bipolar disorder","volume":"151","author":"Tuna","year":"2023","journal-title":"Psychoneuroendocrinology"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"G\u00fcnther, R., Pal, A., Williams, C., Zimyanin, V.L., Liehr, M., von Neubeck, C., Krause, M., Parab, M.G., Petri, S., and Kalmbach, N. (2022). Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS. Cells, 11.","DOI":"10.3390\/cells11071246"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14015439.2022.2092209","article-title":"Chronic respiratory failure negatively affects speech function in patients with bulbar and spinal onset amyotrophic lateral sclerosis: Retrospective data from a tertiary referral center","volume":"49","author":"Sarmet","year":"2024","journal-title":"Logoped. Phoniatr. Vocol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Apreleva Kolomeytseva, A.T., Brylev, L., Eshghi, M., Bottaeva, Z., Zhang, J., Fachner, J.C., and Street, A.J. (2022). Home-Based Music Therapy to Support Bulbar and Respiratory Functions of Persons with Early and Mid-Stage Amyotrophic Lateral Sclerosis\u2014Protocol and Results from a Feasibility Study. Brain Sci., 12.","DOI":"10.3390\/brainsci12040494"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dong, H., Zhang, H., Cai, L., Ye, Q., Wang, H., Liu, B., Zhang, W., and Li, J. (2024). Inflammatory Signaling Induces Mitochondrial Dysfunction and Neuronal Death in Traumatic Brain Injury via Downregulation of OXPHOS Genes. Biochem. Genet.","DOI":"10.1007\/s10528-024-10980-6"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1452849","DOI":"10.3389\/fimmu.2024.1452849","article-title":"IL6 receptor inhibitors: Exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization","volume":"15","author":"Fu","year":"2024","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1038\/s41467-021-23691-y","article-title":"Proline\/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis","volume":"12","author":"Babu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"RP89694","DOI":"10.7554\/eLife.89694","article-title":"C9orf72 polyPR directly binds to various nuclear transport components","volume":"12","author":"Jafarinia","year":"2023","journal-title":"Elife"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e01625","DOI":"10.1002\/brb3.1625","article-title":"FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders","volume":"10","author":"Zhou","year":"2020","journal-title":"Brain Behav."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"114626","DOI":"10.1016\/j.celrep.2024.114626","article-title":"ALS-FUS mutations cause abnormal PARylation and histone H1.2 interaction, leading to pathological changes","volume":"43","author":"Alirzayeva","year":"2024","journal-title":"Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"214190","DOI":"10.1016\/j.bioadv.2025.214190","article-title":"Single-cell RNA sequencing reveals the role of immune-related autophagy in aseptic loosening of biomaterials bone-implant","volume":"169","author":"Wen","year":"2025","journal-title":"Biomater. Adv."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Tzeplaeff, L., J\u00fcrs, A.V., Wohnrade, C., and Demleitner, A.F. (2024). Unraveling the Heterogeneity of ALS\u2014A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials. Cells, 13.","DOI":"10.3390\/cells13050452"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40337-024-01019-7","article-title":"Energy expenditure during nutritional rehabilitation: A scoping review to investigate hypermetabolism in individuals with anorexia nervosa","volume":"12","author":"Reed","year":"2024","journal-title":"J. Eat. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.toxrep.2023.04.010","article-title":"Disease-associated metabolic pathways affected by heavy metals and metalloid","volume":"10","author":"Haidar","year":"2023","journal-title":"Toxicol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Olufunmilayo, E.O., Gerke-Duncan, M.B., and Holsinger, R.M.D. (2023). Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants, 12.","DOI":"10.3390\/antiox12020517"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"108365","DOI":"10.1016\/j.mrrev.2021.108365","article-title":"Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer","volume":"787","author":"Caliri","year":"2021","journal-title":"Mutat. Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zuo, H.-L., Huang, H.-Y., Lin, Y.-C.-D., Cai, X.-X., Kong, X.-J., Luo, D.-L., Zhou, Y.-H., and Huang, H.-D. (2022). Enzyme Activity of Natural Products on Cytochrome P450. Molecules, 27.","DOI":"10.3390\/molecules27020515"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Alshehri, R.S., Abuzinadah, A.R., Alrawaili, M.S., Alotaibi, M.K., Alsufyani, H.A., Alshanketi, R.M., and AlShareef, A.A. (2024). A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252010900"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"105323","DOI":"10.1016\/j.ebiom.2024.105323","article-title":"Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: Validation and implications for clinical trial design and analysis","volume":"108","author":"Benatar","year":"2024","journal-title":"eBioMedicine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/acn3.51697","article-title":"Identification of potential pathways and biomarkers linked to progression in ALS","volume":"10","author":"Huber","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1007\/s00415-024-12699-1","article-title":"Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS","volume":"271","author":"Gagliardi","year":"2024","journal-title":"J. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"fcae268","DOI":"10.1093\/braincomms\/fcae268","article-title":"A microRNA diagnostic biomarker for amyotrophic lateral sclerosis","volume":"6","author":"Banack","year":"2024","journal-title":"Brain Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mus.27818","article-title":"Neurofilament light-chain response during therapy with antisense oligonucleotide tofersen in SOD1-related ALS: Treatment experience in clinical practice","volume":"67","author":"Meyer","year":"2023","journal-title":"Muscle Nerve"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1394001","DOI":"10.3389\/fneur.2024.1394001","article-title":"Phosphorylated neurofilament heavy chain in cerebrospinal fluid and plasma as a Nusinersen treatment response marker in childhood-onset SMA individuals from Serbia","volume":"15","author":"Garai","year":"2024","journal-title":"Front. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Orlova, A., Malygin, Y., Gofman, A., Sotulenko, S., Gandalian, V., Kartashov, I., Brylev, L., Bolevich, S., Nikolic Turnic, T., and Jakovljevic, V. (2024). Survival Prognostic Factors of Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A Systematic Review. Life, 14.","DOI":"10.3390\/life14121664"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fncel.2020.00117","article-title":"Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis","volume":"14","author":"Rumora","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41593-021-01006-0","article-title":"Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines","volume":"25","author":"Baxi","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1309568","DOI":"10.3389\/fnins.2023.1309568","article-title":"Cystatin C is associated with poor survival in amyotrophic lateral sclerosis patients","volume":"17","author":"Jiang","year":"2024","journal-title":"Front. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"120753","DOI":"10.1016\/j.jns.2023.120753","article-title":"Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms","volume":"452","author":"Lee","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12916-023-03120-1","article-title":"Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: A prospective cohort study","volume":"21","author":"Lin","year":"2023","journal-title":"BMC Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41598-020-80370-6","article-title":"Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS","volume":"11","author":"Brodovitch","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"107917","DOI":"10.1016\/j.intimp.2021.107917","article-title":"Infliximab and tocilizumab reduce anxiety-like behavior, improve cognitive performance and reverse neuropathological alterations in juvenile rats with severe autoimmune arthritis","volume":"99","author":"Poutoglidou","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Hosaka, T., Tsuji, H., and Tamaoka, A. (2021). Biomolecular Modifications Linked to Oxidative Stress in Amyotrophic Lateral Sclerosis: Determining Promising Biomarkers Related to Oxidative Stress. Processes, 9.","DOI":"10.3390\/pr9091667"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Parvanovova, P., Evinova, A., Grofik, M., Hnilicova, P., Tatarkova, Z., and Turcanova-Koprusakova, M. (2024). Mitochondrial Dysfunction in Sporadic Amyotrophic Lateral Sclerosis Patients: Insights from High-Resolution Respirometry. Biomedicines, 12.","DOI":"10.3390\/biomedicines12061294"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Cieminski, K., Flis, D.J., Dzik, K.P., Kaczor, J.J., Wieckowski, M.R., Antosiewicz, J., and Ziolkowski, W. (2022). Swim Training Affects on Muscle Lactate Metabolism, Nicotinamide Adenine Dinucleotides Concentration, and the Activity of NADH Shuttle Enzymes in a Mouse Model of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911504"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s40478-023-01648-0","article-title":"A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons","volume":"11","author":"Beckers","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s40478-022-01421-9","article-title":"Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: Evidence for multifaceted pathways underlying neurodegeneration","volume":"10","author":"Trist","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-019-0342-4","article-title":"Autophagy protein NRBF2 has reduced expression in Alzheimer\u2019s brains and modulates memory and amyloid-beta homeostasis in mice","volume":"14","author":"Lachance","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Kitaoka, Y., Uchihashi, T., Kawata, S., Nishiura, A., Yamamoto, T., Hiraoka, S., Yokota, Y., Isomura, E.T., Kogo, M., and Tanaka, S. (2025). Role and Potential of Artificial Intelligence in Biomarker Discovery and Development of Treatment Strategies for Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094346"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13024-024-00753-5","article-title":"Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer\u2019s disease","volume":"19","author":"Zeng","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1351555","DOI":"10.3389\/fsysb.2024.1351555","article-title":"Advancing precision medicine therapeutics for Parkinson\u2019s utilizing a shared quantitative systems pharmacology model and framework","volume":"4","author":"Denaro","year":"2024","journal-title":"Front. Syst. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"102648","DOI":"10.1016\/j.nicl.2021.102648","article-title":"Ultra-high field (7T) functional magnetic resonance imaging in amyotrophic lateral sclerosis: A pilot study","volume":"30","author":"Barry","year":"2021","journal-title":"NeuroImage Clin."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.semnuclmed.2024.09.007","article-title":"Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis","volume":"54","author":"Cumbers","year":"2024","journal-title":"Semin. Nucl. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1418320","DOI":"10.3389\/fneur.2024.1418320","article-title":"Neuroinflammation and glycosylation-related cerebrospinal fluid proteins for predicting functional decline in amyotrophic lateral sclerosis: A proteomic study","volume":"15","author":"Nakamura","year":"2024","journal-title":"Front. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"103633","DOI":"10.1016\/j.nicl.2024.103633","article-title":"Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging study","volume":"43","author":"Abrahao","year":"2024","journal-title":"NeuroImage Clin."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1038\/s41467-021-27221-8","article-title":"Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins","volume":"12","author":"Altman","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"103222","DOI":"10.1016\/j.nicl.2022.103222","article-title":"Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers","volume":"36","author":"Tondo","year":"2022","journal-title":"NeuroImage Clin."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3174\/ajnr.A7823","article-title":"Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics","volume":"44","author":"Milella","year":"2023","journal-title":"Am. J. Neuroradiol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Sneha, N.P., Dharshini, S.A.P., Taguchi, Y.-h., and Gromiha, M.M. (2024). Tracing ALS Degeneration: Insights from Spinal Cord and Cortex Transcriptomes. Genes, 15.","DOI":"10.3390\/genes15111431"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"fcae359","DOI":"10.1093\/braincomms\/fcae359","article-title":"The use of 7T MRI in multiple sclerosis: Review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative","volume":"6","author":"Harrison","year":"2024","journal-title":"Brain Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/mrm.27189","article-title":"High-resolution whole-brain diffusion MRI at 7T using radiofrequency parallel transmission","volume":"80","author":"Wu","year":"2018","journal-title":"Magn. Reson. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp-2022-329993","article-title":"Motor cortex functional connectivity is associated with underlying neurochemistry in ALS","volume":"94","author":"Dey","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"682100","DOI":"10.3389\/fnins.2021.682100","article-title":"Cognitive Profiles of Amyotrophic Lateral Sclerosis Differ in Resting-State Functional Connectivity: An fMRI Study","volume":"15","author":"Temp","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1274979","DOI":"10.3389\/fncel.2023.1274979","article-title":"Synaptic remodeling follows upper motor neuron hyperexcitability in a rodent model of TDP-43","volume":"17","author":"Dyer","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10548-023-00965-w","article-title":"Cortical and Subcortical Changes in MEG Activity Reflect Parkinson\u2019s Progression over a Period of 7 Years","volume":"36","author":"Boon","year":"2023","journal-title":"Brain Topogr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12974-021-02122-1","article-title":"Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy","volume":"18","author":"Fairley","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00401-024-02822-x","article-title":"The microglial translocator protein (TSPO) in Alzheimer\u2019s disease reflects a phagocytic phenotype","volume":"148","author":"Garland","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1038\/s41467-023-40937-z","article-title":"Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases","volume":"14","author":"Nutma","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Salerno, S., Viviano, M., Baglini, E., Poggetti, V., Giorgini, D., Castagnoli, J., Barresi, E., Castellano, S., Da Settimo, F., and Taliani, S. (2024). TSPO Radioligands for Neuroinflammation: An Overview. Molecules, 29.","DOI":"10.3390\/molecules29174212"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"106574","DOI":"10.1016\/j.nbd.2024.106574","article-title":"Neurochemical changes in the progression of Huntington\u2019s disease: A meta-analysis of in vivo 1H-MRS studies","volume":"199","author":"Jing","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13229-023-00577-y","article-title":"Increased cerebral lactate levels in adults with autism spectrum disorders compared to non-autistic controls: A magnetic resonance spectroscopy study","volume":"14","author":"Maier","year":"2023","journal-title":"Mol. Autism"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"15515","DOI":"10.1038\/s41598-023-42760-4","article-title":"Oxidative stress induces mitochondrial iron overload and ferroptotic cell death","volume":"13","author":"Chen","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Ka\u0161telan, S., Gverovi\u0107 Antunica, A., Puzovi\u0107, V., Didovi\u0107 Pavi\u010di\u0107, A., \u010canovi\u0107, S., Kova\u010devi\u0107, P., Vu\u010demilovi\u0107, P.A.F., and Konjevoda, S. (2025). Non-Invasive Retinal Biomarkers for Early Diagnosis of Alzheimer\u2019s Disease. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020283"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Onciul, R., Tataru, C.-I., Dumitru, A.V., Crivoi, C., Serban, M., Covache-Busuioc, R.-A., Radoi, M.P., and Toader, C. (2025). Artificial Intelligence and Neuroscience: Transformative Synergies in Brain Research and Clinical Applications. J. Clin. Med., 14.","DOI":"10.3390\/jcm14020550"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"929151","DOI":"10.3389\/fnins.2022.929151","article-title":"Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: Power calculations for group studies","volume":"16","author":"Behler","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Behler, A., M\u00fcller, H.-P., Ludolph, A.C., and Kassubek, J. (2023). Diffusion Tensor Imaging in Amyotrophic Lateral Sclerosis: Machine Learning for Biomarker Development. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24031911"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41591-022-02160-z","article-title":"The next generation of evidence-based medicine","volume":"29","author":"Subbiah","year":"2023","journal-title":"Nat. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18488\/90.v9i1.2897","article-title":"Electrophysiological Biomarkers for the Assessment of Motor Efficiency in Sport","volume":"9","author":"Cano","year":"2022","journal-title":"J. Sports Res."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Campanini, I., Merlo, A., Disselhorst-Klug, C., Mesin, L., Muceli, S., and Merletti, R. (2022). Fundamental Concepts of Bipolar and High-Density Surface EMG Understanding and Teaching for Clinical, Occupational, and Sport Applications: Origin, Detection, and Main Errors. Sensors, 22.","DOI":"10.3390\/s22114150"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s41983-021-00301-8","article-title":"Motor unit number estimation versus compound muscle action potential in the evaluation of motor unit loss in amyotrophic lateral sclerosis","volume":"57","author":"Ibrahem","year":"2021","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"00159","DOI":"10.1183\/23120541.00159-2017","article-title":"Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation","volume":"4","author":"Sancho","year":"2018","journal-title":"ERJ Open Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s40478-020-01101-6","article-title":"Mitochondrial defects in the respiratory complex I contribute to impaired translational initiation via ROS and energy homeostasis in SMA motor neurons","volume":"8","author":"Thelen","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"D\u0105browska, K., Zaczek, Z., Panczyk, M., Osowska, S., Kowalczyk, P., Kramkowski, K., and Sobocki, J. (2023). Molecular Oxygen Levels and Percentages of DNA Damage in TPN Patients. Nutrients, 15.","DOI":"10.3390\/nu15092206"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.arbres.2023.01.009","article-title":"Effect of the Early Combination of Continuous Positive Airway Pressure and High-Flow Nasal Cannula on Mortality and Intubation Rates in Patients with COVID-19 and Acute Respiratory Distress Syndrome. The DUOCOVID Study","volume":"59","author":"Najera","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Arnold, F.J., Putka, A.F., Raychaudhuri, U., Hsu, S., Bedlack, R.S., Bennett, C.L., and La Spada, A.R. (2024). Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115587"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.stemcr.2023.12.007","article-title":"Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons","volume":"19","author":"Shum","year":"2024","journal-title":"Stem Cell Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nmd.2023.02.004","article-title":"A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy","volume":"33","author":"Barrois","year":"2023","journal-title":"Neuromuscul. Disord. NMD"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Gamucci, F., Pallante, M., Molle, S., Merlo, E., and Bertuglia, A. (2022). A Preliminary Study on the Use of HD-sEMG for the Functional Imaging of Equine Superficial Muscle Activation during Dynamic Mobilization Exercises. Animals, 12.","DOI":"10.3390\/ani12060785"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mus.27824","article-title":"Assessment of motor unit firing by high-density surface electromyography detects motor neuronal hyperexcitable state in amyotrophic lateral sclerosis","volume":"68","author":"Noto","year":"2023","journal-title":"Muscle Nerve"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Pikor, D., Hur\u0142a, M., S\u0142owikowski, B., Szymanowicz, O., Poszwa, J., Banaszek, N., Drelichowska, A., Jagodzi\u0144ski, P.P., Kozubski, W., and Dorszewska, J. (2024). Calcium Ions in the Physiology and Pathology of the Central Nervous System. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252313133"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.clinph.2019.12.007","article-title":"The evolving role of surface electromyography in amyotrophic lateral sclerosis: A systematic review","volume":"131","author":"Bashford","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Ketabforoush, A., Wang, M., and Arnold, W.D. (2024). Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models. J. Vis. Exp.","DOI":"10.3791\/66452"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/brain\/awae131","article-title":"Revisiting distinct nerve excitability patterns in patients with amyotrophic lateral sclerosis","volume":"147","author":"Goedee","year":"2024","journal-title":"Brain"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Huang, H., and Shakkottai, V.G. (2023). Targeting Ion Channels and Purkinje Neuron Intrinsic Membrane Excitability as a Therapeutic Strategy for Cerebellar Ataxia. Life, 13.","DOI":"10.3390\/life13061350"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Krsek, A., Jagodic, A., and Baticic, L. (2024). Nanomedicine in Neuroprotection, Neuroregeneration, and Blood\u2013Brain Barrier Modulation: A Narrative Review. Medicina, 60.","DOI":"10.3390\/medicina60091384"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1321872","DOI":"10.3389\/fnint.2024.1321872","article-title":"Bioelectronic Medicine: A multidisciplinary roadmap from biophysics to precision therapies","volume":"18","author":"Conde","year":"2024","journal-title":"Front. Integr. Neurosci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12984-024-01345-6","article-title":"Online prediction of sustained muscle force from individual motor unit activities using adaptive surface EMG decomposition","volume":"21","author":"Zhao","year":"2024","journal-title":"J. Neuroeng. Rehabil."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Donaghy, R., and Pioro, E.P. (2024). Neurophysiologic Innovations in ALS: Enhancing Diagnosis, Monitoring, and Treatment Evaluation. Brain Sci., 14.","DOI":"10.20944\/preprints202411.0009.v1"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41746-025-01471-y","article-title":"Convergence of evolving artificial intelligence and machine learning techniques in precision oncology","volume":"8","author":"Fountzilas","year":"2025","journal-title":"NPJ Digit. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2022.07.005","article-title":"Fast versus slow disease progression in amyotrophic lateral sclerosis-clinical and genetic factors at the edges of the survival spectrum","volume":"119","author":"Witzel","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neurobiolaging.2021.07.008","article-title":"Mutation analysis of SOD1, C9orf72, TARDBP and FUS genes in ethnically-diverse Malaysian patients with amyotrophic lateral sclerosis (ALS)","volume":"108","author":"Edgar","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41435-022-00192-6","article-title":"Gene\u2013environment interactions and their impact on human health","volume":"24","author":"Virolainen","year":"2023","journal-title":"Genes Immun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"106718","DOI":"10.1016\/j.nbd.2024.106718","article-title":"Specific analysis of SOD1 enzymatic activity in CSF from ALS patients with and without SOD1 mutations","volume":"202","author":"Leykam","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"771911","DOI":"10.3389\/fnmol.2021.771911","article-title":"Mutant Cu\/Zn Superoxide Dismutase (A4V) Turnover Is Altered in Cells Containing Inclusions","volume":"14","author":"Farrawell","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Toader, C., Tataru, C.P., Munteanu, O., Serban, M., Covache-Busuioc, R.-A., Ciurea, A.V., and Enyedi, M. (2024). Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer\u2019s, Parkinson\u2019s, and ALS. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252312613"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1383453","DOI":"10.3389\/fmolb.2024.1383453","article-title":"Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS","volume":"11","author":"Tsekrekou","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Belosludtseva, N.V., Matveeva, L.A., and Belosludtsev, K.N. (2023). Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316833"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mitoco.2025.01.001","article-title":"Decoding the influence of mitochondrial Ca2+ regulation on neurodegenerative disease progression","volume":"3","author":"Sun","year":"2025","journal-title":"Mitochondrial Commun."},{"key":"ref_135","first-page":"32","article-title":"Mitochondrial quality control in human health and disease","volume":"11","author":"Liu","year":"2024","journal-title":"Mil. Med. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fphys.2020.00694","article-title":"Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases","volume":"11","author":"Zucca","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_137","first-page":"1701","article-title":"High serum 8-hydroxy-2\u2032-deoxyguanosine levels predict DNA damage and aging in professional divers","volume":"67","author":"Gunes","year":"2021","journal-title":"Rev. Assoc. Medica Bras. 1992"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e2870","DOI":"10.1002\/brb3.2870","article-title":"Oxidative stress disrupts the cytoskeleton of spinal motor neurons","volume":"13","author":"Chen","year":"2023","journal-title":"Brain Behav."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s10741-021-10109-6","article-title":"Mitochondrial abnormalities: A hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress","volume":"27","author":"Li","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Yamashita, T., and Abe, K. (2024). Update on Antioxidant Therapy with Edaravone: Expanding Applications in Neurodegenerative Diseases. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052945"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"De Marchi, F., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A.A., Mele, A., Vidatic, L., Kriz, J., and Julien, J.-P. (2023). Emerging Trends in the Field of Inflammation and Proteinopathy in ALS\/FTD Spectrum Disorder. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061599"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-024-00416-x","article-title":"Variability in SOD1-associated amyotrophic lateral sclerosis: Geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications","volume":"13","author":"Huang","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1408159","DOI":"10.3389\/fnmol.2024.1408159","article-title":"Copper toxicity and deficiency: The vicious cycle at the core of protein aggregation in ALS","volume":"17","author":"Min","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Landolfo, E., Cutuli, D., Decandia, D., Balsamo, F., Petrosini, L., and Gelfo, F. (2023). Environmental Enrichment Protects against Neurotoxic Effects of Lipopolysaccharide: A Comprehensive Overview. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065404"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.3390\/cimb46060358","article-title":"The Neuromuscular Disorder Mediated by Extracellular Vesicles in Amyotrophic Lateral Sclerosis","volume":"46","author":"Carata","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/17582024.2024.2402216","article-title":"Tofersen for SOD1 ALS","volume":"14","author":"Everett","year":"2024","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Cantara, S., Simoncelli, G., and Ricci, C. (2024). Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202402.1738.v1"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e38583","DOI":"10.1016\/j.heliyon.2024.e38583","article-title":"Amyotrophic lateral sclerosis diagnosis using machine learning and multi-omic data integration","volume":"10","author":"Su","year":"2024","journal-title":"Heliyon"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Kortazar-Zubizarreta, I., Manero-Azua, A., Afonso-Ag\u00fcera, J., and Perez de Nanclares, G. (2023). C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia. J. Pers. Med., 13.","DOI":"10.3390\/jpm13091396"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Kinger, S., Dubey, A.R., Kumar, P., Jagtap, Y.A., Choudhary, A., Kumar, A., Prajapati, V.K., Dhiman, R., and Mishra, A. (2023). Molecular Chaperones\u2019 Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis. Cells, 12.","DOI":"10.3390\/cells12091302"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s40478-020-01060-y","article-title":"RNA dependent suppression of C9orf72 ALS\/FTD associated neurodegeneration by Matrin-3","volume":"8","author":"Ramesh","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Ghasemi, M., Keyhanian, K., and Douthwright, C. (2021). Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Cells, 10.","DOI":"10.3390\/cells10020249"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e1012454","DOI":"10.1371\/journal.ppat.1012454","article-title":"HPV induced R-loop formation represses innate immune gene expression while activating DNA damage repair pathways","volume":"20","author":"Templeton","year":"2024","journal-title":"PLoS Pathog."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neurobiolaging.2021.04.030","article-title":"Translation of the poly(GR) frame in C9ORF72-ALS\/FTD is regulated by cis-elements involved in alternative splicing","volume":"105","author":"Lampasona","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40478-020-01036-y","article-title":"Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity","volume":"8","author":"Quaegebeur","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.molcel.2019.03.019","article-title":"C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function","volume":"74","author":"White","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Taha, M.S., and Ahmadian, M.R. (2024). Nucleophosmin: A Nucleolar Phosphoprotein Orchestrating Cellular Stress Responses. Cells, 13.","DOI":"10.3390\/cells13151266"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41598-022-08724-w","article-title":"C9orf72 dipeptides disrupt the nucleocytoplasmic transport machinery and cause TDP-43 mislocalisation to the cytoplasm","volume":"12","author":"Ryan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"112134","DOI":"10.1016\/j.celrep.2023.112134","article-title":"Loss of C9orf72 perturbs the Ran-GTPase gradient and nucleocytoplasmic transport, generating compositionally diverse Importin \u03b2-1 granules","volume":"42","author":"McGoldrick","year":"2023","journal-title":"Cell Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.neuron.2021.05.020","article-title":"C9orf72 deficiency promotes microglial mediated synaptic loss in aging and amyloid accumulation","volume":"109","author":"Lall","year":"2021","journal-title":"Neuron"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e0243419","DOI":"10.1371\/journal.pone.0243419","article-title":"Determining the effects of nanoparticulate air pollution on proteostasis in Caenorhabditis elegans","volume":"15","author":"Green","year":"2020","journal-title":"PLoS ONE"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"5563759","DOI":"10.1155\/2022\/5563759","article-title":"A Common Feature of Pesticides: Oxidative Stress\u2014The Role of Oxidative Stress in Pesticide-Induced Toxicity","volume":"2022","author":"Sule","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"103795","DOI":"10.1016\/j.ebiom.2021.103795","article-title":"Unraveling the complex interplay between genes, environment, and climate in ALS","volume":"75","author":"Vasta","year":"2021","journal-title":"eBioMedicine"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JND-210754","article-title":"Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials","volume":"9","author":"Querin","year":"2022","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41467-024-55550-x","article-title":"Dual-targeting CRISPR-CasRx reduces C9orf72 ALS\/FTD sense and antisense repeat RNAs in vitro and in vivo","volume":"16","author":"Kempthorne","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neuron.2019.11.007","article-title":"Antibody therapy targeting RAN proteins rescues C9 ALS\/FTD phenotypes in C9orf72 mouse model","volume":"105","author":"Nguyen","year":"2020","journal-title":"Neuron"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/s41467-020-19396-3","article-title":"Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS\/FTD models","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/ars.2018.7518","article-title":"Autophagy: A Lysosome-Dependent Process with Implications in Cellular Redox Homeostasis and Human Disease","volume":"30","author":"Ryter","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jocn.2015.12.039","article-title":"Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation","volume":"32","author":"Aizawa","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40478-024-01729-8","article-title":"Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS\/FTD","volume":"12","author":"Ueda","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1093\/nar\/gkad319","article-title":"Cytoplasmic aggregation of mutant FUS causes multistep RNA splicing perturbations in the course of motor neuron pathology","volume":"51","author":"Rezvykh","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"112025","DOI":"10.1016\/j.celrep.2023.112025","article-title":"FUS ALS neurons activate major stress pathways and reduce translation as an early protective mechanism against neurodegeneration","volume":"42","author":"Szewczyk","year":"2023","journal-title":"Cell Rep."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-021-21912-y","article-title":"Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1016\/j.cell.2023.09.006","article-title":"Formation, function, and pathology of RNP granules","volume":"186","author":"Ripin","year":"2023","journal-title":"Cell"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Keyzor, I., Shohet, S., Castelli, J., Sitaraman, S., Veleva-Rotse, B., Weimer, J.M., Fox, B., Willer, T., Tuske, S., and Crathorne, L. (2023). Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification. Biomolecules, 13.","DOI":"10.3390\/biom13081227"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Bedja-Iacona, L., Richard, E., Marouillat, S., Brulard, C., Alouane, T., Beltran, S., Andres, C.R., Blasco, H., Corcia, P., and Veyrat-Durebex, C. (2024). Post-Translational Variants of Major Proteins in Amyotrophic Lateral Sclerosis Provide New Insights into the Pathophysiology of the Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168664"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"689687","DOI":"10.3389\/fmolb.2021.689687","article-title":"Phosphorylation Regulates CIRBP Arginine Methylation, Transportin-1 Binding and Liquid-Liquid Phase Separation","volume":"8","author":"Lenard","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Bennett, S.A., Cobos, S.N., Fisher, R.M.A., Son, E., Frederic, R., Segal, R., Yousuf, H., Chan, K., Dansu, D.K., and Torrente, M.P. (2025). Direct and Indirect Protein Interactions Link FUS Aggregation to Histone Post-Translational Modification Dysregulation and Growth Suppression in an ALS\/FTD Yeast Model. J. Fungi, 11.","DOI":"10.3390\/jof11010058"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1038\/s41467-021-23187-9","article-title":"Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects","volume":"12","author":"Kan","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Guerra San Juan, I., Brunner, J., Eggan, K., Toonen, R.F., and Verhage, M. (2024). KIF5A regulates axonal repair and time-dependent axonal transport of SFPQ granules and mitochondria in human motor neurons. bioRxiv.","DOI":"10.1101\/2024.09.06.611684"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41467-024-45978-6","article-title":"FUS unveiled in mitochondrial DNA repair and targeted ligase-1 expression rescues repair-defects in FUS-linked motor neuron disease","volume":"15","author":"Kodavati","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Niu, Y., Pal, A., Szewczyk, B., Japtok, J., Naumann, M., Gla\u00df, H., and Hermann, A. (2024). Cell-Type-Dependent Recruitment Dynamics of FUS Protein at Laser-Induced DNA Damage Sites. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063526"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"104648","DOI":"10.1016\/j.nbd.2019.104648","article-title":"Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis","volume":"134","author":"Yang","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"13269","DOI":"10.1093\/nar\/gkae942","article-title":"ALS-associated FUS mutation reshapes the RNA and protein composition of stress granules","volume":"52","author":"Mariani","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41419-021-03873-8","article-title":"Stress granules, RNA-binding proteins and polyglutamine diseases: Too much aggregation?","volume":"12","author":"Marcelo","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s12031-022-02029-3","article-title":"Autophagy Dysfunction in ALS: From Transport to Protein Degradation","volume":"72","author":"Cozzi","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.1021\/acs.jpcb.4c04663","article-title":"The Effect of Dipeptide Repeat Proteins on FUS\/TDP43-RNA Condensation in C9orf72 ALS\/FTD","volume":"128","author":"Driver","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"105716","DOI":"10.1016\/j.jbc.2024.105716","article-title":"RNA and the RNA-binding protein FUS act in concert to prevent TDP-43 spatial segregation","volume":"300","author":"Demongin","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-021-00477-w","article-title":"Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation","volume":"16","author":"Dieterle","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Tamaki, Y., and Urushitani, M. (2022). Molecular Dissection of TDP-43 as a Leading Cause of ALS\/FTLD. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012508"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s40478-024-01914-9","article-title":"Decoding TDP-43: The molecular chameleon of neurodegenerative diseases","volume":"12","author":"Zeng","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 Pathology in Alzheimer\u2019s Disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e53890","DOI":"10.15252\/embr.202153890","article-title":"Gel-like inclusions of C-terminal fragments of TDP-43 sequester stalled proteasomes in neurons","volume":"23","author":"Riemenschneider","year":"2022","journal-title":"EMBO Rep."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Jiang, L.-L., Zhang, X.-L., and Hu, H.-Y. (2024). Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212380"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40035-021-00268-9","article-title":"RNA targets of TDP-43: Which one is more important in neurodegeneration?","volume":"11","author":"Halim","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Zafar, S., Fatima, S.I., Schmitz, M., and Zerr, I. (2024). Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration. Biomolecules, 14.","DOI":"10.3390\/biom14010118"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12929-023-00921-7","article-title":"Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera","volume":"30","author":"Tseng","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"103396","DOI":"10.1016\/j.mcn.2019.103396","article-title":"TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration","volume":"100","author":"Gao","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Meng, K., Jia, H., Hou, X., Zhu, Z., Lu, Y., Feng, Y., Feng, J., Xia, Y., Tan, R., and Cui, F. (2025). Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020327"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"eabb3774","DOI":"10.1126\/scitranslmed.abb3774","article-title":"C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy","volume":"12","author":"Cook","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"663637","DOI":"10.3389\/fneur.2021.663637","article-title":"TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12672-024-01158-y","article-title":"Ataxin-2: A powerful RNA-binding protein","volume":"15","author":"Li","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1038\/s41467-024-51676-0","article-title":"ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes","volume":"15","author":"Harschnitz","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_205","first-page":"e15","article-title":"Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients","volume":"69","author":"Cintra","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40478-020-01055-9","article-title":"Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions","volume":"8","author":"Watanabe","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.molcel.2023.05.025","article-title":"Poly(A)-binding protein is an ataxin-2 chaperone that regulates biomolecular condensates","volume":"83","author":"Boeynaems","year":"2023","journal-title":"Mol. Cell"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/s41467-024-47167-x","article-title":"Halogen doped graphene quantum dots modulate TDP-43 phase separation and aggregation in the nucleus","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1242925","DOI":"10.3389\/fnmol.2023.1242925","article-title":"Phase separation and pathologic transitions of RNP condensates in neurons: Implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders","volume":"16","author":"Naskar","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10048-015-0441-5","article-title":"Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate","volume":"16","author":"Fittschen","year":"2015","journal-title":"Neurogenetics"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Alessandrini, F., Wright, M., Kurosaki, T., Maquat, L.E., and Kiskinis, E. (2024). ALS-Associated TDP-43 Dysfunction Compromises UPF1-Dependent mRNA Metabolism Pathways Including Alternative Polyadenylation and 3\u2032UTR Length. bioRxiv.","DOI":"10.1101\/2024.01.31.578311"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"key":"ref_213","unstructured":"(clinicaltrials.gov, 2024). Parc de Salut Mar Modulation of the Motor Pathway by Transcranial Pulse Stimulation in People with ALS: A Pilot Randomized Trial, clinicaltrials.gov."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Modesti, L., Danese, A., Angela Maria Vitto, V., Ramaccini, D., Aguiari, G., Gaf\u00e0, R., Lanza, G., Giorgi, C., and Pinton, P. (2021). Mitochondrial Ca2+ Signaling in Health, Disease and Therapy. Cells, 10.","DOI":"10.3390\/cells10061317"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"105289","DOI":"10.1016\/j.nbd.2021.105289","article-title":"Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression","volume":"152","author":"Sen","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"107413","DOI":"10.1016\/j.jbc.2024.107413","article-title":"PolyQ-expanded ataxin-2 aggregation impairs cellular processing-body homeostasis via sequestering the RNA helicase DDX6","volume":"300","author":"Wang","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.7150\/ijbs.98051","article-title":"Enhancing mitophagy by ligustilide through BNIP3-LC3 interaction attenuates oxidative stress-induced neuronal apoptosis in spinal cord injury","volume":"20","author":"Yao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s42466-019-0025-1","article-title":"New alternative splicing variants of the ATXN2 transcript","volume":"1","author":"Nonis","year":"2019","journal-title":"Neurol. Res. Pract."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"102395","DOI":"10.1016\/j.apmt.2024.102395","article-title":"Revolutionizing cancer treatment via bioengineered extracellular vesicles: Exploring nanovesicles to fully synthetic solutions","volume":"40","author":"Shao","year":"2024","journal-title":"Appl. Mater. Today"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Al-Khayri, J.M., Ravindran, M., Banadka, A., Vandana, C.D., Priya, K., Nagella, P., and Kukkemane, K. (2024). Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies. Pharmaceuticals, 17.","DOI":"10.3390\/ph17101391"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Tzeplaeff, L., Wilfling, S., Requardt, M.V., and Herdick, M. (2023). Current State and Future Directions in the Therapy of ALS. Cells, 12.","DOI":"10.3390\/cells12111523"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.mcpro.2024.100737","article-title":"Personalized Drug Therapy: Innovative Concept Guided with Proteoformics","volume":"23","author":"Su","year":"2024","journal-title":"Mol. Cell. Proteom. MCP"},{"key":"ref_223","unstructured":"Sanofi (2025, February 12). Care (Canadian ALS Riluzole Evaluation) Multicentre Phase IV Comparative Study of the Effects of Riluzole 50mg Bid on the Survival of ALS Subjects Compared to Historical Controls, clinicaltrials.gov, Clinical Trial Registration NCT00542412, October 2007, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00542412."},{"key":"ref_224","unstructured":"AB Science (2025, February 12). Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel Group, Phase 2\/3 Study to Compare the Efficacy and Safety of Masitinib, clinicaltrials.gov, Clinical Trial Registration NCT02588677, September 2023, Available online: https:\/\/clinicaltrials.gov\/study\/NCT02588677."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Shandiz, E., Fernandes, G.L., Henkin, J.S., McCombe, P.A., Trajano, G.S., and Henderson, R.D. (2024). Assessing the Effect of Riluzole on Motor Unit Discharge Properties. Brain Sci., 14.","DOI":"10.3390\/brainsci14111053"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Cha, S.J., and Kim, K. (2022). Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection. Antioxidants, 11.","DOI":"10.3390\/antiox11020195"},{"key":"ref_227","unstructured":"Lynch, D. (2025, February 01). A Pilot Investigator Initiated Study to Evaluate the Safety, Tolerability and Efficacy of Elamipretide in the Treatment of Advanced Symptoms of Friedreich Ataxia (FRDA), clinicaltrials.gov, Clinical Trial Registration NCT05168774, August 2024, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05168774."},{"key":"ref_228","unstructured":"Mitsubishi Tanabe Pharma America Inc (2025, February 12). Safety Study of Oral Edaravone Administered in Subjects with ALS, clinical-trials.gov, Clinical Trial Registration NCT04165824, May 2023, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04165824."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Firdaus, Z., and Li, X. (2024). Epigenetic Explorations of Neurological Disorders, the Identification Methods, and Therapeutic Avenues. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111658"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/acn3.51915","article-title":"Pooled Resource Open-Access ALS Clinical Trials Consortium Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls","volume":"10","author":"Paganoni","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Sivakumar, S., Ghasemi, M., and Schachter, S.C. (2022). Targeting NMDA Receptor Complex in Management of Epilepsy. Pharmaceuticals, 15.","DOI":"10.3390\/ph15101297"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2147\/NDT.S457591","article-title":"Memantine-Assisted Treatment of N-Methyl-D-Aspartate Receptor Antibody Encephalitis: A Mini Review","volume":"20","author":"Liu","year":"2024","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"661412","DOI":"10.3389\/fncel.2021.661412","article-title":"The Effect of GLT-1 Upregulation on Extracellular Glutamate Dynamics","volume":"15","author":"Wilkie","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1466953","DOI":"10.3389\/fphar.2024.1466953","article-title":"Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy","volume":"15","author":"Kyllo","year":"2024","journal-title":"Front. Pharmacol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/cns.14190","article-title":"Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction","volume":"29","author":"Ng","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1007\/s00415-024-12435-9","article-title":"Update on recent advances in amyotrophic lateral sclerosis","volume":"271","author":"Riva","year":"2024","journal-title":"J. Neurol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"108932","DOI":"10.1016\/j.isci.2024.108932","article-title":"Serum amyloid A and mitochondrial DNA in extracellular vesicles are novel markers for detecting traumatic brain injury in a mouse model","volume":"27","author":"Tang","year":"2024","journal-title":"Iscience"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Yip, J.M.X., Chiang, G.S.H., Lee, I.C.J., Lehming-Teo, R., Dai, K., Dongol, L., Wang, L.Y.-T., Teo, D., Seah, G.T., and Lehming, N. (2025). Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26010364"},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Liu, J., Ting, J.P., Al-Azzam, S., Ding, Y., and Afshar, S. (2021). Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062805"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1086895","DOI":"10.3389\/fncel.2023.1086895","article-title":"Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology","volume":"17","author":"Diab","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"841036","DOI":"10.3389\/fnins.2022.841036","article-title":"Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation","volume":"16","author":"Abulseoud","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Montiel-Troya, M., Mohamed-Mohamed, H., Pardo-Moreno, T., Gonz\u00e1lez-D\u00edaz, A., Ruger-Navarrete, A., de la Mata Fern\u00e1ndez, M., Tovar-G\u00e1lvez, M.I., Ramos-Rodr\u00edguez, J.J., and Garc\u00eda-Morales, V. (2024). Advancements in Pharmacological Interventions and Novel Therapeutic Approaches for Amyotrophic Lateral Sclerosis. Biomedicines, 12.","DOI":"10.3390\/biomedicines12102200"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Fang, T., Je, G., Pacut, P., Keyhanian, K., Gao, J., and Ghasemi, M. (2022). Gene Therapy in Amyotrophic Lateral Sclerosis. Cells, 11.","DOI":"10.3390\/cells11132066"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-020-00373-9","article-title":"From basic research to the clinic: Innovative therapies for ALS and FTD in the pipeline","volume":"15","author":"Liscic","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Vinceti, G., Gallingani, C., Zucchi, E., Martinelli, I., Gianferrari, G., Simonini, C., Bedin, R., Chiari, A., Zamboni, G., and Mandrioli, J. (2023). Young Onset Alzheimer\u2019s Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association. Genes, 14.","DOI":"10.3390\/genes14040930"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awab006","article-title":"Long-read targeted sequencing uncovers clinicopathological associations for C9orf72-linked diseases","volume":"144","author":"Aleff","year":"2021","journal-title":"Brain"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13024-024-00790-0","article-title":"Targeted long-read sequencing to quantify methylation of the C9orf72 repeat expansion","volume":"19","author":"Udine","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"e70109","DOI":"10.1111\/cns.70109","article-title":"Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia Parkinsonism","volume":"30","author":"Petrozziello","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/acsptsci.4c00028","article-title":"Protein Corona Composition of Gold Nanocatalysts","volume":"7","author":"Ashkarran","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"2304082","DOI":"10.1002\/smll.202304082","article-title":"A Mechanism Underpinning the Bioenergetic Metabolism-Regulating Function of Gold Nanocatalysts","volume":"20","author":"Wang","year":"2024","journal-title":"Small"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"102036","DOI":"10.1016\/j.eclinm.2023.102036","article-title":"Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): A phase 2, randomised, double-blind, placebo-controlled trial and open label extension","volume":"60","author":"Vucic","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"789331","DOI":"10.3389\/fcvm.2022.789331","article-title":"SS31 Ameliorates Oxidative Stress via the Restoration of Autophagic Flux to Protect Aged Mice From Hind Limb Ischemia","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mus.27091","article-title":"Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis","volume":"63","author":"Paganoni","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_255","first-page":"216","article-title":"The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review\u2019s Midwest Comparative Effectiveness Public Advisory Council","volume":"29","author":"Nikitin","year":"2023","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.1038\/s41467-024-52600-2","article-title":"USF2 and TFEB compete in regulating lysosomal and autophagy genes","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","article-title":"Targeting the biology of aging with mTOR inhibitors","volume":"3","author":"Mannick","year":"2023","journal-title":"Nat. Aging"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"212969","DOI":"10.1016\/j.bioadv.2022.212969","article-title":"Trehalose-releasing nanogels: A step toward a trehalose delivery vehicle for autophagy stimulation","volume":"138","author":"Maruf","year":"2022","journal-title":"Biomater. Adv."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"102133","DOI":"10.1016\/j.omtn.2024.102133","article-title":"Tissue pharmacokinetics of antisense oligonucleotides","volume":"35","author":"Bonetti","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"31461","DOI":"10.1038\/s41598-024-82967-7","article-title":"Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: Insights from molecular dynamics simulations and experimental validation","volume":"14","author":"Ngernsombat","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41420-024-02277-9","article-title":"Mitochondria-targeted antioxidant MitoQ radiosensitizes tumors by decreasing mitochondrial oxygen consumption","volume":"10","author":"Rondeau","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"116142","DOI":"10.1016\/j.jphotochem.2024.116142","article-title":"Antioxidant capacity of edaravone, quercetin, and myricetin involving probabilistic fluctuations using eosin-Y and eosin-B as fluorescent probes in the ORAC assay","volume":"460","author":"Takatsuka","year":"2025","journal-title":"J. Photochem. Photobiol. Chem."},{"key":"ref_263","unstructured":"Biogen (2025, February 02). Global Early Access Program to Provide Tofersen To Patients with Amyotrophic Lateral Sclerosis (ALS) Associated with a Mutation in the Superoxide Dismutase 1 (SOD1) Gene, clinicaltrials.gov, Clinical Trial Registration NCT04972487, June 2024, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04972487."},{"key":"ref_264","unstructured":"Biogen (2025, February 12). An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB067 Administered to Previously Treated Adults with Amyotrophic Lateral Sclerosis Caused by Superoxide Dismutase 1 Mutation, clinicaltrials.gov, Clinical Trial Registration NCT03070119, August 2024, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03070119."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40259-024-00644-7","article-title":"Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases","volume":"38","author":"Chen","year":"2024","journal-title":"BioDrugs"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neurol.2024.03.008","article-title":"C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?","volume":"180","author":"Sellier","year":"2024","journal-title":"Rev. Neurol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/jnc.15847","article-title":"Aspects of degradation and translation of the expanded C9orf72 hexanucleotide repeat RNA","volume":"166","author":"Mori","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/WCO.0000000000000984","article-title":"Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia","volume":"34","author":"Hautbergue","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1223777","DOI":"10.3389\/fnins.2023.1223777","article-title":"CRISPR\/Cas9: Implication for modeling and therapy of amyotrophic lateral sclerosis","volume":"17","author":"Shi","year":"2023","journal-title":"Front. Neurosci."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-Nanoparticle-Based Delivery of CRISPR\/Cas9 Genome-Editing Components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol. Pharm."},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Seifert, A., Drechsler, H., Japtok, J., Korten, T., Diez, S., and Hermann, A. (2021). The ALS-Associated FUS (P525L) Variant Does Not Directly Interfere with Microtubule-Dependent Kinesin-1 Motility. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052422"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41434-022-00375-w","article-title":"In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model","volume":"30","author":"Chen","year":"2023","journal-title":"Gene Ther."},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Amanat, M., Nemeth, C.L., Fine, A.S., Leung, D.G., and Fatemi, A. (2022). Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112389"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1259435","DOI":"10.3389\/fchem.2023.1259435","article-title":"Biomaterials-mediated CRISPR\/Cas9 delivery: Recent challenges and opportunities in gene therapy","volume":"11","author":"Dubey","year":"2023","journal-title":"Front. Chem."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1238453","DOI":"10.3389\/fnmol.2023.1238453","article-title":"Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis","volume":"16","author":"Stansberry","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"102280","DOI":"10.1016\/j.omtn.2024.102280","article-title":"Emerging trends in virus and virus-like particle gene therapy delivery to the brain","volume":"35","author":"Mandalawatta","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"100086","DOI":"10.1016\/j.crneur.2023.100086","article-title":"Advances in AAV technology for delivering genetically encoded cargo to the nonhuman primate nervous system","volume":"4","author":"Campos","year":"2023","journal-title":"Curr. Res. Neurobiol."},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Reddy, D.S., and Abeygunaratne, H.N. (2022). Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911734"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.7150\/thno.83066","article-title":"New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)","volume":"13","author":"Palanisamy","year":"2023","journal-title":"Theranostics"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","article-title":"NurOwn, phase 2, randomized, clinical trial in patients with ALS","volume":"93","author":"Berry","year":"2019","journal-title":"Neurology"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/stcltm\/szad041","article-title":"Neural Cells for Neurodegenerative Diseases in Clinical Trials","volume":"12","author":"Fan","year":"2023","journal-title":"Stem Cells Transl. Med."},{"key":"ref_282","first-page":"346","article-title":"Stem cell therapy in neurological disorders: Promises and concerns","volume":"3","year":"2023","journal-title":"Explor. Neuroprot. Ther."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Ore, A., Angelastro, J.M., and Giulivi, C. (2024). Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases. Brain Sci., 14.","DOI":"10.3390\/brainsci14090899"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/mus.27472","article-title":"A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis","volume":"65","author":"Cudkowicz","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_285","unstructured":"Brainstorm-Cell Therapeutics (2025, February 12). A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn\u00ae (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants with ALS, clinicaltrials.gov, Clinical Trial Registration NCT03280056, February 2024, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03280056."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/acn3.51887","article-title":"Therapeutic targeting of ALS pathways: Refocusing an incomplete picture","volume":"10","author":"Maragakis","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Kaminska, A., Radoszkiewicz, K., Rybkowska, P., Wedzinska, A., and Sarnowska, A. (2022). Interaction of Neural Stem Cells (NSCs) and Mesenchymal Stem Cells (MSCs) as a Promising Approach in Brain Study and Nerve Regeneration. Cells, 11.","DOI":"10.3390\/cells11091464"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13287-021-02217-9","article-title":"hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice","volume":"12","author":"Kong","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s13287-020-02008-8","article-title":"Human adipose-derived stem cells enriched with VEGF-modified mRNA promote angiogenesis and long-term graft survival in a fat graft transplantation model","volume":"11","author":"Yu","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40824-023-00381-y","article-title":"CRISPR\/Cas9 assisted stem cell therapy in Parkinson\u2019s disease","volume":"27","author":"Pinjala","year":"2023","journal-title":"Biomater. Res."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.2147\/IJN.S407029","article-title":"Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases","volume":"18","author":"Yuan","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12929-024-01075-w","article-title":"Extracellular vesicle therapy in neurological disorders","volume":"31","author":"Putthanbut","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"ref_293","unstructured":"Nassar, W.F. (2025, February 12). Phase 1 Study of The Effect of Cell-Free Cord Blood Derived Microvesicles On \u03b2-cell Mass in Type 1 Diabetes Mellitus (T1DM) Patients, clinicaltrials.gov, Clinical Trial Registration NCT02138331, May 2014, Available online: https:\/\/clinicaltrials.gov\/study\/NCT02138331."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awae204","article-title":"Brain repair mechanisms after cell therapy for stroke","volume":"147","author":"Rust","year":"2024","journal-title":"Brain"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"107622","DOI":"10.1016\/j.celrep.2020.107622","article-title":"A Biomarker for Predicting Responsiveness to Stem Cell Therapy Based on Mechanism-of-Action: Evidence from Cerebral Injury","volume":"31","author":"Hartman","year":"2020","journal-title":"Cell Rep."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s40001-024-01987-1","article-title":"Stem cell therapies for neurological disorders: Current progress, challenges, and future perspectives","volume":"29","author":"Seyedoshohadaei","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12964-024-01752-1","article-title":"Advancing stroke therapy: Innovative approaches with stem cell-derived extracellular vesicles","volume":"22","author":"Song","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-020-01822-4","article-title":"Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis","volume":"17","author":"Christoforidou","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_299","doi-asserted-by":"crossref","unstructured":"You, J., Youssef, M.M.M., Santos, J.R., Lee, J., and Park, J. (2023). Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential. Biology, 12.","DOI":"10.3390\/biology12101307"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1128190","DOI":"10.3389\/fimmu.2023.1128190","article-title":"Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases","volume":"14","author":"Boraschi","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"552295","DOI":"10.3389\/fneur.2020.552295","article-title":"Plasma Inflammatory Cytokines Are Elevated in ALS","volume":"11","author":"Tortelli","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"e0232612","DOI":"10.1371\/journal.pone.0232612","article-title":"Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells","volume":"15","author":"Lokau","year":"2020","journal-title":"PLoS ONE"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12876-021-01827-0","article-title":"Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice","volume":"21","author":"Randhi","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"ref_304","doi-asserted-by":"crossref","unstructured":"Chiarini, A., Gui, L., Viviani, C., Armato, U., and Dal Pr\u00e0, I. (2023). NLRP3 Inflammasome\u2019s Activation in Acute and Chronic Brain Diseases-An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes. Biomedicines, 11.","DOI":"10.3390\/biomedicines11040999"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12964-022-00859-7","article-title":"mTORC2: A multifaceted regulator of autophagy","volume":"21","author":"Sun","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cstres.2024.03.010","article-title":"Impact of histone deacetylase inhibition and arimoclomol on heat shock protein expression and disease biomarkers in primary culture models of familial ALS","volume":"29","author":"Minotti","year":"2024","journal-title":"Cell Stress Chaperones"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1212\/WNL.0000000000004960","article-title":"Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS","volume":"90","author":"Benatar","year":"2018","journal-title":"Neurology"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"768023","DOI":"10.3389\/fphar.2021.768023","article-title":"Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders","volume":"12","author":"Shah","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/jdad1020006","article-title":"Endoplasmic Reticulum Stress in Neurodegenerative Diseases","volume":"1","author":"Hasan","year":"2024","journal-title":"J. Dement. Alzheimers Dis."},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Gebert, M., S\u0142awski, J., Kalinowski, L., Collawn, J.F., and Bartoszewski, R. (2023). The Unfolded Protein Response: A Double-Edged Sword for Brain Health. Antioxidants, 12.","DOI":"10.3390\/antiox12081648"},{"key":"ref_312","doi-asserted-by":"crossref","unstructured":"Kurumi, H., Yokoyama, Y., Hirano, T., Akita, K., Hayashi, Y., Kazama, T., Isomoto, H., and Nakase, H. (2024). Cytokine Profile in Predicting the Effectiveness of Advanced Therapy for Ulcerative Colitis: A Narrative Review. Biomedicines, 12.","DOI":"10.3390\/biomedicines12050952"},{"key":"ref_313","doi-asserted-by":"crossref","unstructured":"Mo\u021b\u0103\u021b\u0103ianu, A., Andone, S., Stoian, A., B\u0103la\u0219a, R., Hu\u021banu, A., and S\u0103rm\u0103\u0219an, E. (2024). A Potential Role of Interleukin-5 in the Pathogenesis and Progression of Amyotrophic Lateral Sclerosis: A New Molecular Perspective. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073782"},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Cunha-Oliveira, T., Montezinho, L., Sim\u00f5es, R.F., Carvalho, M., Ferreiro, E., and Silva, F.S.G. (2024). Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis. Cells, 13.","DOI":"10.3390\/cells13030248"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/WCO.0000000000001164","article-title":"Abnormal energy metabolism in ALS: A key player?","volume":"36","author":"Burg","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","article-title":"Hypermetabolism in ALS is associated with greater functional decline and shorter survival","volume":"89","author":"Steyn","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1437521","DOI":"10.3389\/fnut.2024.1437521","article-title":"Association between dietary patterns and the prognosis of amyotrophic lateral sclerosis in China: A cross-sectional study","volume":"11","author":"Xu","year":"2024","journal-title":"Front. Nutr."},{"key":"ref_318","doi-asserted-by":"crossref","unstructured":"Kousparou, C., Fyrilla, M., Stephanou, A., and Patrikios, I. (2023). DHA\/EPA (Omega-3) and LA\/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310717"},{"key":"ref_319","doi-asserted-by":"crossref","unstructured":"Dickerson, B., Maury, J., Jenkins, V., Nottingham, K., Xing, D., Gonzalez, D.E., Leonard, M., Kendra, J., Ko, J., and Yoo, C. (2024). Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women. Nutrients, 16.","DOI":"10.3390\/nu16070990"},{"key":"ref_320","doi-asserted-by":"crossref","unstructured":"Ahmad, Y., Seo, D.S., and Jang, Y. (2024). Metabolic Effects of Ketogenic Diets: Exploring Whole-Body Metabolism in Connection with Adipose Tissue and Other Metabolic Organs. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137076"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1329541","DOI":"10.3389\/fneur.2023.1329541","article-title":"Time-restricted ketogenic diet in amyotrophic lateral sclerosis: A case study","volume":"14","author":"Phillips","year":"2024","journal-title":"Front. Neurol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"947567","DOI":"10.3389\/fnut.2022.947567","article-title":"Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention","volume":"9","author":"Saris","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"1149618","DOI":"10.3389\/fneur.2023.1149618","article-title":"Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration","volume":"14","author":"Solanki","year":"2023","journal-title":"Front. Neurol."},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"Markowiak-Kope\u0107, P., and \u015ali\u017cewska, K. (2020). The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients, 12.","DOI":"10.3390\/nu12041107"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"110841","DOI":"10.1016\/j.exger.2020.110841","article-title":"Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan","volume":"132","author":"Sutphin","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3803\/EnM.2023.1659","article-title":"Brown Adipose Tissue: Activation and Metabolism in Humans","volume":"38","author":"Hachemi","year":"2023","journal-title":"Endocrinol. Metab."},{"key":"ref_327","doi-asserted-by":"crossref","unstructured":"Wu, X., Zhang, C., Liang, Z., Liang, Y., Li, Y., and Qiu, J. (2024). Exercise Combined with a Low-Calorie Diet Improves Body Composition, Attenuates Muscle Mass Loss, and Regulates Appetite in Adult Women with High Body Fat Percentage but Normal BMI. Sports, 12.","DOI":"10.3390\/sports12040091"},{"key":"ref_328","doi-asserted-by":"crossref","unstructured":"Ga\u0142\u0119ska, E., Kowalczyk, A., Wrzeci\u0144ska, M., Garc\u00eda, M.C., Czerniawska-Pi\u0105tkowska, E., Gwo\u017adziewicz, S., Witkiewicz, W., and Dobrza\u0144ski, Z. (2025). The Importance of Mitochondrial Processes in the Maturation and Acquisition of Competences of Oocytes and Embryo Culture. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094098"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/gidisord6040056","article-title":"Impact of Probiotics and Prebiotics on Gut Microbiome and Hormonal Regulation","volume":"6","author":"Basnet","year":"2024","journal-title":"Gastrointest. Disord."},{"key":"ref_330","first-page":"CD004427","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","volume":"2017","author":"Radunovic","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/aor.14244","article-title":"Non-invasive phrenic nerve stimulation to avoid ventilator-induced diaphragm dysfunction in critical care","volume":"46","author":"Keogh","year":"2022","journal-title":"Artif. Organs"},{"key":"ref_332","first-page":"CD004030","article-title":"Enteral tube feeding for amyotrophic lateral sclerosis\/motor neuron disease","volume":"2023","author":"Sulistyo","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1007\/s00415-023-11838-4","article-title":"The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"270","author":"Zhu","year":"2023","journal-title":"J. Neurol."},{"key":"ref_334","unstructured":"UCB Pharma (2025, February 12). A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for KemstroTM Com-pared to Conventional Baclofen Tablets in Subjects with Stable Multiple Sclerosis, clinicaltrials.gov, Clinical Trial Registration NCT00139789, August 2013, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00139789."},{"key":"ref_335","unstructured":"Teva GTC (2025, February 12). A Double-Blind, Randomized, Two-Way Crossover, Comparative Study to Evaluate the Clinical Efficacy and Safety of Novel Sublingual Tizanidine HCl Versus Placebo in Children with Chronic Traumatic Brain Injury, clinicaltrials.gov, Clinical Trial Regis Tration NCT00287157, January 2009, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00287157."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"1432330","DOI":"10.3389\/fneur.2024.1432330","article-title":"Multimodal therapy and use of adjunctive therapies to BoNT-A in spasticity management: Defining terminology to help enhance spasticity treatment","volume":"15","author":"Reebye","year":"2024","journal-title":"Front. Neurol."},{"key":"ref_337","first-page":"19","article-title":"Sialorrhea in patients with ALS: Current treatment options","volume":"9","author":"Garuti","year":"2019","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_338","doi-asserted-by":"crossref","unstructured":"Hung, S.-A., Liao, C.-L., Lin, W.-P., Hsu, J.C., Guo, Y.-H., and Lin, Y.-C. (2021). Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis. Children, 8.","DOI":"10.3390\/children8121089"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fneur.2018.00603","article-title":"Communication Matters\u2014Pitfalls and Promise of Hightech Communication Devices in Palliative Care of Severely Physically Disabled Patients with Amyotrophic Lateral Sclerosis","volume":"9","author":"Linse","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.wneu.2024.05.104","article-title":"Bridging Minds and Machines: The Recent Advances of Brain-Computer Interfaces in Neurological and Neurosurgical Applications","volume":"189","author":"Awuah","year":"2024","journal-title":"World Neurosurg."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12904-024-01429-z","article-title":"Optimizing breathlessness management in amyotrophic lateral sclerosis: Insights from a comprehensive systematic review","volume":"23","author":"Filipe","year":"2024","journal-title":"BMC Palliat. Care"},{"key":"ref_342","doi-asserted-by":"crossref","unstructured":"Candelise, N., Salvatori, I., Scaricamazza, S., Nesci, V., Zenuni, H., Ferri, A., and Valle, C. (2022). Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship. Metabolites, 12.","DOI":"10.3390\/metabo12030233"},{"key":"ref_343","doi-asserted-by":"crossref","unstructured":"Zhao, J., Wang, X., Huo, Z., Chen, Y., Liu, J., Zhao, Z., Meng, F., Su, Q., Bao, W., and Zhang, L. (2022). The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis. Cells, 11.","DOI":"10.3390\/cells11132049"},{"key":"ref_344","doi-asserted-by":"crossref","unstructured":"Sighencea, M.G., Popescu, R.\u0218., and Trifu, S.C. (2024). From Fundamentals to Innovation in Alzheimer\u2019s Disease: Molecular Findings and Revolutionary Therapies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212311"},{"key":"ref_345","doi-asserted-by":"crossref","unstructured":"Cihankaya, H., Theiss, C., and Matschke, V. (2021). Little Helpers or Mean Rogue\u2014Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22030993"},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: A neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"1196413","DOI":"10.3389\/fphar.2023.1196413","article-title":"Alzheimer\u2019s disease and neuroinflammation: Will new drugs in clinical trials pave the way to a multi-target therapy?","volume":"14","author":"Melchiorri","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12974-024-03163-y","article-title":"Tracking neuroinflammatory biomarkers in Alzheimer\u2019s disease: A strategy for individualized therapeutic approaches?","volume":"21","author":"Lista","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"ref_349","doi-asserted-by":"crossref","unstructured":"Vidovic, M., M\u00fcschen, L.H., Brakemeier, S., Machetanz, G., Naumann, M., and Castro-Gomez, S. (2023). Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis. Cells, 12.","DOI":"10.3390\/cells12050736"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40035-024-00419-8","article-title":"In vivo diagnosis of TDP-43 proteinopathies: In search of biomarkers of clinical use","volume":"13","author":"Corrochano","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/acscentsci.3c00213","article-title":"Target Identification of a Class of Pyrazolone Protein Aggregation Inhibitor Therapeutics for Amyotrophic Lateral Sclerosis","volume":"10","author":"Weerawarna","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"ref_352","doi-asserted-by":"crossref","unstructured":"Cox, S.N., Giudice, C.L., Lavecchia, A., Poeta, M.L., Chiara, M., Picardi, E., and Pesole, G. (2024). Mitochondrial and Nuclear DNA Variants in Amyotrophic Lateral Sclerosis: Enrichment in the Mitochondrial Control Region and Sirtuin Pathway Genes in Spinal Cord Tissue. Biomolecules, 14.","DOI":"10.3390\/biom14040411"},{"key":"ref_353","doi-asserted-by":"crossref","unstructured":"Nguyen, L. (2024). Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis. Cells, 13.","DOI":"10.3390\/cells13110888"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-021-02206-y","article-title":"Short structural variants as informative genetic markers for ALS disease risk and progression","volume":"20","author":"Theunissen","year":"2022","journal-title":"BMC Med."},{"key":"ref_355","doi-asserted-by":"crossref","unstructured":"Ortega-Robles, E., de Celis Alonso, B., Cantillo-Negrete, J., Carino-Escobar, R.I., and Arias-Carri\u00f3n, O. (2025). Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders. Brain Sci., 15.","DOI":"10.3390\/brainsci15010079"},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00415-022-11520-1","article-title":"Analysis of brain and spinal MRI measures in a common domain to investigate directional neurodegeneration in motor neuron disease","volume":"270","author":"Toh","year":"2023","journal-title":"J. Neurol."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/hmg\/ddac097","article-title":"Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy","volume":"31","author":"Comley","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"ref_358","doi-asserted-by":"crossref","unstructured":"Risi, B., Cotti Piccinelli, S., Gazzina, S., Labella, B., Caria, F., Damioli, S., Poli, L., Padovani, A., and Filosto, M. (2023). Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12155036"},{"key":"ref_359","first-page":"76","article-title":"Targeting RTKs\/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: Evidence from clinical trials","volume":"11","author":"Mehta","year":"2024","journal-title":"Mil. Med. Res."},{"key":"ref_360","doi-asserted-by":"crossref","unstructured":"Crouzier, L., Denus, M., Richard, E.M., Tavernier, A., Diez, C., Cubedo, N., Maurice, T., and Delprat, B. (2021). Sigma-1 Receptor Is Critical for Mitochondrial Activity and Unfolded Protein Response in Larval Zebrafish. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011049"},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddw238","article-title":"Pridopidine activates neuroprotective pathways impaired in Huntington Disease","volume":"25","author":"Geva","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_362","unstructured":"HEALEY ALS (2025, February 12). Platform Trial\u2014Regimen F ABBV-CLS-7262, clinicaltrials.gov, Clinical Trial Registration NCT05740813, January 2025, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05740813."},{"key":"ref_363","doi-asserted-by":"crossref","unstructured":"Speidell, A., Bin Abid, N., and Yano, H. (2023). Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington\u2019s Disease: Mechanisms and Potential Therapeutics. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082275"},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"119021","DOI":"10.1016\/j.bbamcr.2021.119021","article-title":"Expression of C9orf72 hexanucleotide repeat expansion leads to formation of RNA foci and dipeptide repeat proteins but does not influence autophagy or proteasomal function in neuronal cells","volume":"1868","author":"Huber","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s44318-024-00352-6","article-title":"RNA dysregulation in neurodegenerative diseases","volume":"44","author":"Li","year":"2025","journal-title":"EMBO J."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2018.12.005","article-title":"Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson\u2019s disease","volume":"177","author":"Pupyshev","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_367","doi-asserted-by":"crossref","unstructured":"Dawoody Nejad, L., and Pioro, E.P. (2025). Modeling ALS with Patient-Derived iPSCs: Recent Advances and Future Potentials. Brain Sci., 15.","DOI":"10.3390\/brainsci15020134"},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.neuron.2023.01.010","article-title":"Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects","volume":"111","author":"Workman","year":"2023","journal-title":"Neuron"},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/procel\/pwae042","article-title":"Advances in gene and cellular therapeutic approaches for Huntington\u2019s disease","volume":"16","author":"Piao","year":"2024","journal-title":"Protein Cell"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"1144093","DOI":"10.3389\/fphar.2023.1144093","article-title":"Editorial: Mitochondrial therapy in neurodegeneration","volume":"14","author":"Kalani","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/21678421.2020.1788092","article-title":"TRICALS: Creating a highway toward a cure","volume":"21","author":"Kliest","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_372","unstructured":"Biogen (2025, February 02). A Phase 3 Randomized, Placebo-Controlled Trial with a Longitudinal Natural History Run-In and Open-Label Extension to Evaluate BIIB067 Initiated in Clinically Presymptomatic Adults with a Confirmed Superoxide Dismutase 1 Mutation, clinicaltrials.gov, Clinical Trial Registration NCT04856982, June 2024, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04856982."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1186\/s13063-022-06906-5","article-title":"Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: Protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial","volume":"23","author":"Willemse","year":"2022","journal-title":"Trials"},{"key":"ref_374","doi-asserted-by":"crossref","unstructured":"Stanga, S., Caretto, A., Boido, M., and Vercelli, A. (2020). Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103719"},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"eadf6376","DOI":"10.1126\/scitranslmed.adf6376","article-title":"The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates","volume":"15","author":"Anwar","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_376","doi-asserted-by":"crossref","unstructured":"Chorev, M., Haderlein, J., Chandra, S., Menon, G., Burton, B.J.L., Pearce, I., McKibbin, M., Thottarath, S., Karatsai, E., and Chandak, S. (2023). A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1. J. Clin. Med., 12.","DOI":"10.3390\/jcm12083013"},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.parkreldis.2020.12.005","article-title":"A long-term follow-up of safety and clinical efficacy of NTCELL\u00ae [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson\u2019s disease","volume":"82","author":"Mulroy","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"ref_378","first-page":"e44359","article-title":"Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"102497","DOI":"10.1016\/j.arr.2024.102497","article-title":"AI-driven innovations in Alzheimer\u2019s disease: Integrating early diagnosis, personalized treatment, and prognostic modelling","volume":"101","author":"Kale","year":"2024","journal-title":"Ageing Res. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/8072\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:32:31Z","timestamp":1760034751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/8072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":379,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26168072"],"URL":"https:\/\/doi.org\/10.3390\/ijms26168072","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}